Detalhe da pesquisa
1.
MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers.
Mol Cancer Ther
; 18(2): 346-355, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30425131
2.
Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation.
Clin Cancer Res
; 25(17): 5376-5387, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31175091